Magnetic resonance apparent diffusion coefficient values of the brain in COPD  by Shehata, Mohammad El Desouky Abo et al.
Egyptian Journal of Chest Diseases and Tuberculosis xxx (2016) xxx–xxxContents lists available at ScienceDirect
Egyptian Journal of Chest Diseases and Tuberculosis
journal homepage: www.sciencedirect .comMagnetic resonance apparent diffusion coefficient values of the brain in
COPDhttp://dx.doi.org/10.1016/j.ejcdt.2016.11.003
0422-7638/ 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Abbreviations: COPD, chronic obstructive pulmonary disease; DWI, diffusion
weighted imaging; ADC, apparent diffusion coefficient.
Peer review under responsibility of The Egyptian Society of Chest Diseases and
Tuberculosis.
⇑ Corresponding author.
E-mail address: samahahala@yahoo.com (H.M.S. Samaha).
1 Prof. of chest medicine
2 Associate prof. of chest medicine
3 Lecturer of chest medicine
4 Lecturer of radiology
5 Lecturer of neuromedicine
Please cite this article in press as: M.E.D.A. Shehata et al., Magnetic resonance apparent diffusion coefficient values of the brain in COPD, Egypt. J. Ch
Tuberc. (2016), http://dx.doi.org/10.1016/j.ejcdt.2016.11.003Mohammad El Desouky Abo Shehata 1, Hala Mohamed Shalaby Samaha ⇑,2, Amany Ragab Elsaid 3,
Eman Mohamed Helmy 4, Wessam Mustafa 5
Mansoura University, Faculty of Medicine, Egypt
a r t i c l e i n f o a b s t r a c tArticle history:
Received 4 November 2016
Accepted 13 November 2016
Available online xxxx
Keywords:
COPD
DWI
ADC
White matter lesionsObjective: Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow obstruc-
tion. As the disease progresses, it affects several organs and systems. So, the aim of this study was to eval-
uate the efficacy of diffusion-weighted imaging (DWI) of the brain in defining deep white matter integrity
in COPD patients, and correlate apparent diffusion coefficient (ADC) values to COPD stage, pulmonary
function tests and arterial blood gases.
Methods: A cross-sectional case-control study included 20 COPD male patients (smokers), aged
51–78 years and 18 healthy male volunteers, non-smokers with matched age (45–71 years), represented
the control group. All the subjects were neurologically free (on examination) with no known history of
cerebrovascular disease, renal impairment, chronic hepatic disease or any other disease which may have
a cerebral effect. Spirometry, arterial blood gases and COPD staging were done for COPD patients. DWI
was done for both groups.
Results: Both groups were age matched (P 0.231). All apparent diffusion coefficient (ADC) values were
higher in COPD patients than the healthy (control) group. ADC values taken from the frontal, temporal
and parietal deep white matter of COPD patients had statistically significant difference compared to those
of the control group (P values = 0.016 & 0.013 and 0.002 respectively). No significant correlation between
ADC values measured from all lobes and arterial blood gases, FEV1 or COPD staging.
Conclusion: ADC values are increased significantly in COPD patients than in normal populations denoting
affected integrity of white matter, however this increase is not related to COPD severity, arterial hypox-
emia, hypercapnia or other disease markers like FEV1.
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Chronic obstructive pulmonary disease (COPD) is characterized
by progressive airflow obstruction. As the disease progresses, it
affects several organs and systems [1,2]. The systemic effects ofCOPD are caused by oxidative stress and altered circulating levels
of inflammatory mediators and acute-phase proteins [1]. COPD
can cause changes in the cerebral blood flow as well as all vascular
structures [3]. Chronic hypoperfusion is considered to play a signif-
icant role in the development of white matter lesions [4]. In addi-
tion, the systemic inflammation may lead to neuronal damage in
the brain of patients with COPD [5].
Diffusion-weighted imaging (DWI) has become a basic tech-
nique of modern clinical imaging, mainly to investigate the dis-
eased brain. Diffusing water molecules provide unique
information on the white matter microstructure and integrity [6].
DWI is a noninvasive magnetic resonance imaging technique that
is commonly used today. It defines the tissues in relation to the dif-
fusion properties of their water content, particularly with high b
values. DWI can be used to measure quantitatively the increased
free water content in the cerebral tissue caused by damage toest Dis.
2 M.E.D.A. Shehata et al. / Egyptian Journal of Chest Diseases and Tuberculosis xxx (2016) xxx–xxxthe myelin and axons [7,8]. Increased apparent diffusion coefficient
(ADC) values can result from chronic pathological conditions like
chronic hypoxia-ischemia, gliosis and demyelination [8].
The aim of the work
The aim of this study was to evaluate the efficacy of DWI in
defining deep white matter integrity in the patients with COPD,
and correlate apparent diffusion coefficient (ADC) values to COPD
severity staging, pulmonary function tests and arterial blood gases
abnormalities.
Patients and methods
Patients
A cross-sectional case-control study included twenty COPD
male patients (smokers), aged 51–78 years from February 2015
to September 2015, presented at Mansoura University Hospital.
Eighty healthy male volunteers, non-smokers with matched age
(45–71 years), represented the control group. All the subjects were
free from a known history of cerebrovascular disease, renal impair-
ment, chronic hepatic disease or any other disease which may have
a cerebral effect.
COPD diagnosis and staging
The diagnosis and staging of COPD patients was done according
to GOLD guidelines [9]P
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i.org/10.1016/jFEV1 P80% normalStage II Moderate
COPDFEV1/FVC
<0.70FEV1 50–79% normalStage III Severe
COPDFEV1/FVC
<0.70FEV1 30–49% normalStage IV Very
Severe
COPDFEV1/FVC
<0.70FEV1 <30% normal, or
<50% normal with
chronic respiratory
failure presentTable 1
MRI associated findings of COPD patients and the normal control group.
(⁄Independent sample t-test P value 6 0.05 accepted as statistically significant.
MRI associated findings COPD group
(n = 20)
Control group
(n = 18)
P value
White matter hyperintensities:
Grade 1: multiple punctate lesions 5/20 (25%) 2/18 (11.1%) 0.270
Grade 2: initially confluent lesions 3/20 (15%) 1/18 (5.55%) 0.344
Total: 8/20 (40%) 3/18 (16.6%) 0.113
Brain atrophy
Mild atrophy 2/20 (10%) 1/18 (5.55%) 0.612
Moderate atrophy 1/20 (5%) 1/18 (5.55%) 0.939
Total: 3/20 (15%) 2/18 (11.1%) 0.723Pulmonary function tests
Spirometry (BTL-08 spiro, Germany) was performed to deter-
mine the lung function measurements and bronchodilator
reversibility. Post bronchodilator FEV1/FVC% and FEV1 were mea-
sured 15 min after inhalation of 400 lg of salbutamol. Arterial
blood gases were done for COPD cases for assessment of hypox-
emia, hypercapnia or PH changes.
- All patients were assessed neurologically with no evident
abnormal findings.
- No sedative agents were used prior to magnetic resonance
imaging and no contrast administration during the imaging. A
consent was taken from COPD patients and healthy control
group.
Image acquisition
All examinations were performed on a 1.5 T MRI scanner Philips
Ingenie (Philips health care, Heide, Netherland). A clinical MR
imaging brain protocol that included sagittal spin-echo
T1-weighted images, axial T2-weighted, axial fluid-attenuated
inversion recovery sequence (FLAIR) and coronal images were
acquired. Diffusion weighted spin-echo single-shot echo planarShehata et al., Magnetic resonance ap
.ejcdt.2016.11.003pulse sequence used to generate ADC values and acquired by
selecting repetition time 4600 ms-echo time 110 ms-FOV
212 mm-matrix 212  212-NEX 3. Images were obtained with val-
ues of b 0, 500, 1000 mm2/sec. ADC maps of the images were auto-
matically generated and the ADC values were measured on this
map for all patients.
Image analysis
Conventional MRI analysis: FLAIR and T2-weighted images were
used to assess brain atrophy, vascular white matter hyperintensi-
ties and lacunar infarctions.
White matter integrity: A circular region of interest (ROI) was
placed within the cerebral white matter of the frontal, temporal,
parietal and occipital regions on both sides, with exclusion of
partial-voluming with CSF and grey matter. Quantitative measure-
ments of ADC values with a commercially available software pack-
age were derived. For each patient, three measurements were
taken. The mean of the obtained three ADC values was used for
evaluation.
Statistical analysis
Statistical analysis was performed using Statistical Package for
Social Sciences (SPSS) version 20 for Windows. Data were obtained
as mean, standard deviations, minimum and maximum values for
both the COPD and control group. Independent sample t-test as
used for the comparison of means between the two groups. Statis-
tical significance was accepted at the level of P < 0.05. Receiver
operating characteristic (ROC) analysis was performed to evaluate
the diagnostic performance of DWI in defining white matter integ-
rity in COPD patients. Sensitivity, specificity and area under the
curve (AUC) calculations were made for the ADC values. Threshold
values were compared between COPD patients and control groups.
Results
This study included 20 male COPD patients with mean age and
standard deviation were 62.10 ± 7.44 years (range 51–78 years),
and that of the 18 healthy individuals was 58.22 ± 8.87 years
(range 45–71 years). Statistically significant difference was not
detected between the groups for age distribution (P 0.231).
Reviewing the conventional MR images using Fazekas visual
rating scale showed relative increased number and burden of
white matter lesions in COPD patients (40%) compared to (healthy)
control group (16.6%), but with no significant difference
(p = 0.113). No significant increase in brain atrophy in patients
with COPD compared to (healthy) control group (p = 0.723) as
shown in Table 1.
The measurement of ADC values from the frontal, temporal,
parietal and occipital white matter areas of COPD patients andparent diffusion coefficient values of the brain in COPD, Egypt. J. Chest Dis.
Table 3
The diagnostic performance of DWI in defining white matter changes in patients with
COPD. (*Independent sample t-test P value 6 0.05 accepted as statistically significant.
Frontal Parietal Occipital Temporal
Cut off point 0.7971 0.7237 0.7677 0.8391
Area under the curve 0.811 0.883 0.600 0.794
Sensitivity 80% 85% 80% 70%
Specificity 77.8% 77.8% 44.4% 88.9%
P value 0.008⁄ 0.001⁄ 0.396 0.012⁄
Table 2
ADC values measured from the frontal, temporal, parietal and occipital deep white
matter of COPD patients and the normal control group. (⁄Independent sample t-test P
value 6 0.05 accepted as statistically significant.
COPD group (n = 20) Control group (n = 18) P value
Frontal 0.83 ± 0.06  103 mm2/sec 0.77 ± 0.04  103 mm2/sec 0.016⁄
Temporal 0.85 ± 0.02  103 mm2/sec 0.82 ± 0.03  103 mm2/sec 0.013⁄
Parietal 0.78 ± 0.06  103 mm2/sec 0.80 ± 0.06  103 mm2/sec 0.002⁄
Occipital 0.81 ± 0.09  103 mm2/sec 0.78 ± 0.06  103 mm2/sec 0.727
Figure 2. Mean ADC values in white matter of right frontal region
(0.97  103 mm2/sec), left frontal region (0.985  103 mm2/sec), right occipital
region (0.948  103 mm2/sec) and left occipital region (0.927  103 mm2/sec) of
70-year-old male with COPD.
M.E.D.A. Shehata et al. / Egyptian Journal of Chest Diseases and Tuberculosis xxx (2016) xxx–xxx 3the healthy (control) group are shown as mean values ± standard
deviations in Table 2. All ADC measurements were higher in COPD
patients than the healthy (control) group. There was statistically
significant difference in the ADC values taken from the frontal,
temporal and parietal deep white matter of the COPD patients
compared to those of the healthy (control) group (P values = 0.016
& 0.013 and 0.002 respectively).
The ROC analysis was used to evaluate the diagnostic perfor-
mance of DWI in defining white matter changes in patients with
COPD (Table 3) & Fig. 1. DWI had high sensitivity and specificity
in defining frontal, parietal and temporal white matter changes.1 - Specificity
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Figure 3. Mean ADC values in white matter of right parietal region
(0.961  103 mm2/sec), left parietal region (0.804  103 mm2/sec) of 64-year-
old male with COPD.
Figure 4. Mean ADC values in white matter of right temporal region
(0.923  103 mm2/sec) of 55-year-old COPD patient.
Figure 5. Mean ADC values in white matter of right frontal region
(0.738  103 mm2/sec), left frontal region (0.764  103 mm2/sec), right occipital
region (0.793  103 mm2/sec) and left occipital region (0.771  103 mm2/sec) of
60-year-old healthy (control) male.
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Chronic obstructive pulmonary disease (COPD) continues to be
a major cause of morbidity and mortality. It is increasingly recog-
nised that COPD extends beyond the lung to the brain [5].
Diffusion-weighted magnetic resonance imaging provides
potentially unique information on the viability of brain tissue. It
provides image contrast that is dependent on the molecular
motion of water, which may be substantially altered by disease
[10]. Currently, diffusion-weighted imaging is the most reliable
method for detection of early and small ischemic infarcts in the
brain. However, applications of this imaging technique extend far
beyond the work-up of acute ischemia and are increasingly used
for the evaluation of a large variety of neoplastic and non neoplas-
tic conditions affecting the brain (Tables 4 and 5).
In this study standard MRI techniques were used for assessment
of white matter lesions and global brain atrophy, while ADC was
used to assess the white matter integrity quantitatively. We based
our results of white matter hyperintensities on Fazekas scale which
is one of the best visual scales in assessment of age related white
matter changes. This is a four-grade rating scale, absence of lesions
matches to grade 0; presence of non-confluent focal lesions
matches to grade 1; initially confluent lesions matches to grade
2; diffuse confluent lesions matches to grade 3 [11].
Our present study revealed that patients with COPD had no sig-
nificant increase in associated brain atrophy. Such finding coin-
cides with that obtained by Dodd and colleagues [12] who
reported that the patients with COPD did not have generalized
cerebral atrophy.
Our results showed that there is increased number and burden
of white matter lesions in patients with COPD compared with
healthy control group, which is matching also with the results of
Dodd and colleagues [12], who found that white matter lesions
were significantly higher in COPD patients than in control subjects.
ADC is a quantitative measurement of the random microscopic
motion of water molecules in different tissues. ADC values are
increased with the increase of free water content in the white mat-
ter as a result of damage of myelin and axons [13].parent diffusion coefficient values of the brain in COPD, Egypt. J. Chest Dis.
Table 4
Correlation between ADC values measured from the frontal, temporal, parietal, occipital deep white matter of COPD patients and arterial blood gases (pao2, paco2 and ph), FEV1.
No significant correlation between ADC values measured from these lobes and arterial blood gases or FEV1.
Frontal Parietal Occipital Temporal
r P r P r P r P
Pao2 0.414 0.070 0.159 0.502 0.120 0.613 0.179 0.450
Paco2 0.264 0.261 0.013 0.957 0.154 0.518 0.006 0.981
PH 0.487 0.029 0.219 0.353 0.013 0.956 0.095 0.689
FEV1 0.157 0.510 0.078 0.743 0.124 0.604 0.133 0.576
Table 5
Correlation between ADC values measured from the frontal, temporal, parietal and occipital deep white matter of COPD patients and COPD severity (mild, moderate, severe and
very severe). No significant correlation between ADC values measured from these lobes and COPD severity.
Mild (N = 1) Moderate (N = 9) Sever (N = 8) Very sever (N = 2) t P
Frontal 0.821 0.836 ± 0.065 0.823 ± 0.072 0.821 ± 0.030 0.071 0.975
Parietal 0.738 0.793 ± 0.057 0.782 ± 0.077 0.769 ± 0.006 0.260 0.853
Occipital 0.801 0.827 ± 0.068 0.783 ± 0.130 0.819 ± 0.058 0.286 0.835
Temporal 0.841 0.847 ± 0.016 0.847 ± 0.031 0.857 ± 0.004 0.142 0.933
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ues measured in normally appearing white matter of frontal, pari-
etal and temporal lobes on both sides are significantly higher in
COPD patients than in those of healthy (control) group. Also there
is high sensitivity and specificity in defining frontal, temporal and
parietal white matter changes. However there is reduced speci-
ficity in detecting white matter changes in occipital lobes. These
findings support the findings obtained by Cullu et al. [14] who
found that ADC values in the deep white matter of all brain lobes
of patients with COPD to be significantly higher than the control
group.
In this study, ADC values in COPD patients were not correlated
to arterial hypoxemia, hypercapnia or FEV1. These findings were
similar to Dodd and colleagues [12] who provided evidence of sig-
nificant white and gray matter abnormalities associated with cog-
nitive dysfunction in patients with COPD without arterial
hypoxemia or hypercapnia.
James et al. [15], have shown also that in stable non hypoxemic
patients with COPD there was evidence of white matter
microstructural damage throughout the brain In COPD patients
James et al. [15], tested to see whether COPD factors, such as
FEV1 and arterial saturation were related to the degree of white
matter damage, but no associations were found. So, they hypothe-
sized, but cannot prove, that the most likely mechanism is
microvascular damage.
In contrast, van Dijk et al. [16] found that COPD and lower arte-
rial oxygen saturation (SaO2) are associated with severe periven-
tricular white matter lesions. They suggested that both cerebral
hypoperfusion and hypoxemia may be leading causes of periven-
tricular white matter lesions.
The absence of an association between brain damage and other
pulmonary-specific disease markers is not unexpected because
other complex extrapulmonary manifestations of COPD may not
be strongly related to pulmonary markers [17]. For example unex-
plained weight loss has been associated with poor prognosis, inde-
pendent of FEV1 and Pao2 [18]. Till now, the mechanisms
responsible for white matter damage are not fully established.
These findings emphasize the importance of organ dysfunction
outside the lung in the morbidity and mortality associated with the
development of COPD and strengthen the need for a broad
approach to the care of these patients [19]. Further studies are
required to dissect the mechanisms by which smoking, COPD, or
both contribute to white matter abnormalities in patients with
COPD so that targeted interventions can be initiated early in the
disease.Please cite this article in press as: M.E.D.A. Shehata et al., Magnetic resonance ap
Tuberc. (2016), http://dx.doi.org/10.1016/j.ejcdt.2016.11.003Conclusion
ADC values are increased significantly in COPD patients than in
normal populations denoting affected integrity of white matter,
however this increase is not related to COPD severity, arterial
hypoxemia, hypercapnia or other disease markers like FEV1.
Chronic hypoperfusion, systemic inflammatory mediators and
cerebral microcirculation defect were considered to play signifi-
cant role in the development of white matter lesions. But the exact
mechanisms responsible for white matter damage are not fully
established.
Recommendations
Further studies (on larger number of patients with different
clinical, laboratory and radiological evaluation) are needed to dis-
cover the extra-pulmonary cerebral manifestations of COPD and
the mechanisms by which smoking, COPD, or both contribute to
white matter and other cerebral abnormalities in patients with
COPD. So that targeted interventions can be initiated early in the
disease
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